153 related articles for article (PubMed ID: 23933538)
1. The addition of niacin to statin therapy improves high-density lipoprotein cholesterol levels but not metrics of functionality.
Khera AV; Patel PJ; Reilly MP; Rader DJ
J Am Coll Cardiol; 2013 Nov; 62(20):1909-10. PubMed ID: 23933538
[No Abstract] [Full Text] [Related]
2. What does the future hold for niacin as a treatment for hyperlipidaemia and cardiovascular disease?
Ahmed MH
J Cardiovasc Med (Hagerstown); 2010 Nov; 11(11):858-60. PubMed ID: 20686417
[TBL] [Abstract][Full Text] [Related]
3. Antioxidants blunt high-density lipoprotein response to statin plus niacin therapy.
Kris-Etherton PM
Curr Atheroscler Rep; 2001 Nov; 3(6):435-6. PubMed ID: 11602062
[No Abstract] [Full Text] [Related]
4. Trial clouds use of niacin with a statin.
Harv Heart Lett; 2011 Aug; 21(12):2. PubMed ID: 21991606
[No Abstract] [Full Text] [Related]
5. Niacin, fenofibrates increase benefits for statin users. These HDL- raising, triglyceride-lowering drugs beat out the use of additional LDL-lowering drugs.
Duke Med Health News; 2010 Aug; 16(8):1-2. PubMed ID: 20799416
[No Abstract] [Full Text] [Related]
6. Effect of niacin on preβ-1 high-density lipoprotein levels in diabetes.
Pan J; Shilian P; Ishida B; Wu X; Kane JP; Malloy MJ; Charles MA
Metabolism; 2011 Feb; 60(2):292-7. PubMed ID: 20303127
[TBL] [Abstract][Full Text] [Related]
7. ARBITER-2 : evidence that targeting HDL cholesterol slows atherosclerosis.
Cardiovasc J S Afr; 2005; 16(1):61. PubMed ID: 15778778
[No Abstract] [Full Text] [Related]
8. The facts behind niacin.
Hochholzer W; Berg DD; Giugliano RP
Ther Adv Cardiovasc Dis; 2011 Oct; 5(5):227-40. PubMed ID: 21893559
[TBL] [Abstract][Full Text] [Related]
9. The effects of simvastatin-niacin and antioxidant therapy on HDL.
Drown DJ
Prog Cardiovasc Nurs; 2002; 17(2):102-3. PubMed ID: 11986546
[No Abstract] [Full Text] [Related]
10. Search and rescue for hypotheses surviving AIM-HIGH, the niacin therapy earthquake: still problematic after the primary publication.
Brinton EA
J Clin Lipidol; 2012; 6(4):312-7. PubMed ID: 22836067
[No Abstract] [Full Text] [Related]
11. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials.
Birjmohun RS; Hutten BA; Kastelein JJ; Stroes ES
J Am Coll Cardiol; 2005 Jan; 45(2):185-97. PubMed ID: 15653014
[TBL] [Abstract][Full Text] [Related]
12. [What is the future for niacin after the AIM-HIGH study?].
Cybulska B; Kłosiewicz Latoszek L
Kardiol Pol; 2012; 70(3):315-6. PubMed ID: 22430425
[No Abstract] [Full Text] [Related]
13. Niacin and statin combination therapy for atherosclerosis regression and prevention of cardiovascular disease events: reconciling the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) trial with previous surrogate endpoint trials.
Michos ED; Sibley CT; Baer JT; Blaha MJ; Blumenthal RS
J Am Coll Cardiol; 2012 Jun; 59(23):2058-64. PubMed ID: 22520249
[TBL] [Abstract][Full Text] [Related]
14. Niacin as a component of combination therapy for dyslipidemia.
Miller M
Mayo Clin Proc; 2003 Jun; 78(6):735-42. PubMed ID: 12934785
[TBL] [Abstract][Full Text] [Related]
15. 'Trig-onometry': non-high-density lipoprotein cholesterol as a therapeutic target in dyslipidaemia.
Jacobson TA
Int J Clin Pract; 2011 Jan; 65(1):82-101. PubMed ID: 21105969
[TBL] [Abstract][Full Text] [Related]
16. [Niacin--an additive therapeutic approach for optimizing lipid profile].
Wieneke H; Schmermund A; Erbel R
Med Klin (Munich); 2005 Apr; 100(4):186-92. PubMed ID: 15834527
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia.
Fazio S; Guyton JR; Polis AB; Adewale AJ; Tomassini JE; Ryan NW; Tershakovec AM
Am J Cardiol; 2010 Feb; 105(4):487-94. PubMed ID: 20152243
[TBL] [Abstract][Full Text] [Related]
18. Commentary: A new approach to atherogenic dyslipidemia.
Reasner CA
Postgrad Med; 2005 Apr; 117(4):13-6. PubMed ID: 15842128
[No Abstract] [Full Text] [Related]
19. Termination of Atherothrombosis Intervention in Metabolic Syndrome with Low High-Density Lipoprotein Cholesterol and High Triglycerides: Impact on Global Health Study and decision to use extended-release niacin in elderly.
Shil AB
J Am Geriatr Soc; 2011 Dec; 59(12):2397-8. PubMed ID: 22188098
[No Abstract] [Full Text] [Related]
20. New focus on raising HDL "good" cholesterol. But the value of this is not entirely clear.
Duke Med Health News; 2012 Feb; 18(2):3. PubMed ID: 22397008
[No Abstract] [Full Text] [Related]
[Next] [New Search]
